{"id":"NCT00529243","sponsor":"Kaiser Permanente","briefTitle":"Evaluating the Effect of CHanging EnfuvirtidE to Raltegravir in HIV Infected Subjects","officialTitle":"Virologic Outcomes of Changing Enfuvirtide to Raltegravir in HIV-1 Patients Well Controlled on an Enfuvirtide Based Regimen","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2007-09","primaryCompletion":"2008-07","completion":"2009-09","firstPosted":"2007-09-14","resultsPosted":"2011-06-08","lastUpdate":"2018-08-07"},"enrollment":52,"design":{"allocation":"NA","model":"SINGLE_GROUP","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["HIV Infections"],"interventions":[{"type":"DRUG","name":"raltegravir","otherNames":["MK-0518, Isentress"]}],"arms":[{"label":"MK-0518 (raltegravir)","type":"EXPERIMENTAL"}],"summary":"The primary objective of this study is:\n\nTo assess the virologic effect of changing enfuvirtide to MK-0518(raltegravir) in human immunodeficiency virus type 1(HIV-1) infected patients who have an undetectable level of serum human immunodeficiency virus(HIV) (\\< 75 copies/ml by branch deoxyribonucleic acid (bDNA) assay, \\< 50 copies/ml by Ultrasensitive Polymerase Chain Reaction(PCR) assay) on their current HIV medication regimen.\n\nHypothesis:\n\nHIV-1 infected individuals well controlled on an enfuvirtide containing regimen with HIV RNA levels below limits of quantification can safely have the investigational integrase inhibitor, MK-0518 substituted for enfuvirtide without loss of virologic suppression.","primaryOutcome":{"measure":"Number of Patients With Undetectable Human Immunodeficiency Virus (HIV) Viral Load at Week 24.","timeFrame":"24 Weeks","effectByArm":[{"arm":"MK-0518 (Raltegravir)","deltaMin":49,"sd":null}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":1,"exclusionCount":1},"locations":{"siteCount":8,"countries":["United States"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":3,"n":52},"commonTop":["alanine aminotransferase (ALT)","Fatigue","serum creatinine elevation"]}}